amemStat3GfapExonBR SequenceGCT ACA and 3 more items

Virginia Commonwealth University has awarded a contract to Integrated DNA Technologies Inc. for the procurement of molecular biology products. The award, issued on June 29, 2026, is valued at twenty-three dollars and encompasses four line items consisting of DNA sequences and related molecular reagents. All deliverables are designated for delivery to Virginia Commonwealth University Procurement in Virginia. The contract line items include three units priced at $6.05 each and one unit priced at $5.45, representing specialized genetic sequences with specific nomenclature designations related to GFAP (glial fibrillary acidic protein) markers and exon/promoter regions.

Integrated DNA Technologies Inc. serves as the prime contractor for this Virginia Commonwealth University procurement action. The individual line items specify distinct DNA sequence products with varying genetic compositions, each ordered in a quantity of one unit and measured individually. This contract represents a small-value procurement typical of research institution acquisitions for laboratory and research support purposes, with Virginia Commonwealth University identified as both the contracting organization and the performance location for receipt of materials.